BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10644979)

  • 1. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
    Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD
    Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T; Thiele CJ
    Oncogene; 1998 Jun; 16(25):3337-43. PubMed ID: 9681834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
    Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
    Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
    Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
    Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
    Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
    Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
    Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation.
    Borriello A; Cucciolla V; Criscuolo M; Indaco S; Oliva A; Giovane A; Bencivenga D; Iolascon A; Zappia V; Della Ragione F
    Cancer Res; 2006 Apr; 66(8):4240-8. PubMed ID: 16618747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
    Bahrami AR; Matin MM; Andrews PW
    Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
    Tomoda K; Kubota Y; Kato J
    Nature; 1999 Mar; 398(6723):160-5. PubMed ID: 10086358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p27kip1 in the in vitro differentiation of murine keratinocytes.
    Hauser PJ; Agrawal D; Flanagan M; Pledger WJ
    Cell Growth Differ; 1997 Feb; 8(2):203-11. PubMed ID: 9040942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1.
    Hirano K; Hirano M; Zeng Y; Nishimura J; Hara K; Muta K; Nawata H; Kanaide H
    Biochem J; 2001 Jan; 353(Pt 1):51-57. PubMed ID: 11115398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2.
    Nakamura M; Matsuo T; Stauffer J; Neckers L; Thiele CJ
    Cell Death Differ; 2003 Feb; 10(2):230-9. PubMed ID: 12700651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
    Kawasaki H; Eckner R; Yao TP; Taira K; Chiu R; Livingston DM; Yokoyama KK
    Nature; 1998 May; 393(6682):284-9. PubMed ID: 9607768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
    Wu Y; Luo H; Kanaan N; Wu J
    J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of p27Kip1 accumulation in murine B-lymphoma cells: role of c-Myc and calcium.
    Donjerković D; Zhang L; Scott DW
    Cell Growth Differ; 1999 Oct; 10(10):695-704. PubMed ID: 10547073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
    Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.